ArabFinance: October Pharma's (OCPH) extraordinary general assembly that held on Dec. 05, 2019, approved the increase of authorized and issued capitals.

The company decided to increase the authorized capital from EGP 60 million to 120 million with an increase amounting to EGP 60 million, in addition to the issued capital increase from EGP 60 million to EGP 120 million, with an increase amounting to EGP 60 million.

The EGM approved amending articles no. 6 and 7 of articles of associations.

It is worth mentioning that the company got Financial Regulatory Authority (FRA) nodded on Oct. 31, 2019, to October Pharma to proceed into procedures of the issued capital increase.

The capital will be increased in cash as well as allocated to existing shareholders according to their quota in the share capital.

Copyright © 2019 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.